Strategies for cardiac regeneration and repair

Science Translational Medicine

Volumn 6, Issue 239, 2014, Pages

  Lin, Zhiqiang ^a   Pu, William T ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; BONE MARROW TRANSPLANTATION; CARDIAC PROGENITOR CELL; CELL CYCLE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CORONARY ARTERY BYPASS GRAFT; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STROMA CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR; CARDIAC MUSCLE CELL; CYTOLOGY; HEART; NUCLEAR REPROGRAMMING; PHYSIOLOGY; REGENERATION; WOUND HEALING;

CELLULAR REPROGRAMMING; HEART; HUMANS; MYOCYTES, CARDIAC; REGENERATION; STEM CELL TRANSPLANTATION; WOUND HEALING;

EID: 84903140599     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006681     Document Type: Review

References (105)

1. A. P. Beltrami, K. Urbanek, J. Kajstura, S. M. Yan, N. Finato, R. Bussani, B. Nadal-Ginard, F. Silvestri, A. Leri, C. A. Beltrami, P. Anversa, Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 344, 1750-1757 (2001).
2. K. L. Ang, L. T. Shenje, S. Reuter, M. H. Soonpaa, M. Rubart, L. J. Field, M. Galiñanes, Limitations of conventional approaches to identify myocyte nuclei in histologic sections of the heart. Am. J. Physiol. Cell Physiol. 298, C1603-C1609 (2010).
3. M. A. Laflamme, C. E. Murry, Heart regeneration. Nature 473, 326-335 (2011).
4. O. Bergmann, R. D. Bhardwaj, S. Bernard, S. Zdunek, F. Barnabé-Heider, S. Walsh, J. Zupicich, K. Alkass, B. A. Buchholz, H. Druid, S. Jovinge, J. Frisén, Evidence for cardiomyocyte renewal in humans. Science 324, 98-102 (2009).
5. S. E. Senyo, M. L. Steinhauser, C. L. Pizzimenti, V. K. Yang, L. Cai, M. Wang, T. D. Wu, J. L. Guerquin-Kern, C. P. Lechene, R. T. Lee, Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433-436 (2013).
6. M. A. Laflamme, C. E. Murry, Regenerating the heart. Nat. Biotechnol. 23, 845-856 (2005).
7. M. H. Soonpaa, L. J. Field, Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am. J. Physiol. 272, H220-H226 (1997).
8. E. R. Porrello, A. I. Mahmoud, E. Simpson, J. A. Hill, J. A. Richardson, E. N. Olson, H. A. Sadek, Transient regenerative potential of the neonatal mouse heart. Science 331, 1078-1080 (2011).
9. M. Mollova, K. Bersell, S. Walsh, J. Savla, L. T. Das, S. Y. Park, L. E. Silberstein, C. G. Dos Remedios, D. Graham, S. Colan, B. Kühn, Cardiomyocyte proliferation contributes to heart growth in young humans. Proc. Natl. Acad. Sci. U.S.A. 110, 1446-1451 (2013).
10. P. Ahuja, P. Sdek, W. R. MacLellan, Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544 (2007).
11. A. He, Q. Ma, J. Cao, A. von Gise, P. Zhou, H. Xie, B. Zhang, M. Hsing, D. C. Christodoulou, P. Cahan, G. Q. Daley, S. W. Kong, S. H. Orkin, C. E. Seidman, J. G. Seidman, W. T. Pu, Polycomb repressive complex 2 regulates normal development of the mouse heart. Circ. Res. 110, 406-415 (2012).
12. P. Sdek, P. Zhao, Y. Wang, C. J. Huang, C. Y. Ko, P. C. Butler, J. N. Weiss, W. R. Maclellan, Rb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytes. J. Cell Biol. 194, 407-423 (2011).
13. R. Agah, L. A. Kirshenbaum, M. Abdellatif, L. D. Truong, S. Chakraborty, L. H. Michael, M. D. Schneider, Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J. Clin. Invest. 100, 2722-2728 (1997).
14. R. J. Hassink, K. B. Pasumarthi, H. Nakajima, M. Rubart, M. H. Soonpaa, A. B. de la Rivière, P. A. Doevendans, L. J. Field, Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc. Res. 78, 18-25 (2008).
15. W. Hong, K. L. Guan, The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin. Cell Dev. Biol. 23, 785-793 (2012).
16. T. Heallen, M. Zhang, J. Wang, M. Bonilla-Claudio, E. Klysik, R. L. Johnson, J. F. Martin, Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 (2011).
17. A. von Gise, Z. Lin, K. Schlegelmilch, L. B. Honor, G. M. Pan, J. N. Buck, Q. Ma, T. Ishiwata, B. Zhou, F. D. Camargo, W. T. Pu, YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 109, 2394-2399 (2012).
18. M. Xin, Y. Kim, L. B. Sutherland, X. Qi, J. McAnally, R. J. Schwartz, J. A. Richardson, R. Bassel-Duby, E. N. Olson, Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70 (2011).
19. T. Heallen, Y. Morikawa, J. Leach, G. Tao, J. T. Willerson, R. L. Johnson, J. F. Martin, Hippo signaling impedes adult heart regeneration. Development 140, 4683-4690 (2013).
20. M. Xin, Y. Kim, L. B. Sutherland, M. Murakami, X. Qi, J. McAnally, E. R. Porrello, A. I. Mahmoud, W. Tan, J. M. Shelton, J. A. Richardson, H. A. Sadek, R. Bassel-Duby, E. N. Olson, Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. U.S.A. 110, 13839-13844 (2013).
21. E. N. Olson, MicroRNAs as therapeutic targets and biomarkers of cardiovascular disease. Sci. Transl. Med. 6, 239ps3 (2014).
22. A. Eulalio, M. Mano, M. Dal Ferro, L. Zentilin, G. Sinagra, S. Zacchigna, M. Giacca, Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381 (2012).
23. J. Chen, Z. P. Huang, H. Y. Seok, J. Ding, M. Kataoka, Z. Zhang, X. Hu, G. Wang, Z. Lin, S. Wang, W. T. Pu, R. Liao, D. Z. Wang, mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Circ. Res. 112, 1557-1566 (2013).
24. E. R. Porrello, A. I. Mahmoud, E. Simpson, B. A. Johnson, D. Grinsfelder, D. Canseco, P. P. Mammen, B. A. Rothermel, E. N. Olson, H. A. Sadek, Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc. Natl. Acad. Sci. U.S.A. 110, 187-192 (2013).
25. S. Welch, D. Plank, S. Witt, B. Glascock, E. Schaefer, S. Chimenti, A. M. Andreoli, F. Limana, A. Leri, J. Kajstura, P. Anversa, M. A. Sussman, Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ. Res. 90, 641-648 (2002).
26. F. B. Engel, M. Schebesta, M. T. Duong, G. Lu, S. Ren, J. B. Madwed, H. Jiang, Y. Wang, M. T. Keating, p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 19, 1175-1187 (2005).
27. O. Odiete, M. F. Hill, D. B. Sawyer, Neuregulin in cardiovascular development and disease. Circ. Res. 111, 1376-1385 (2012).
28. K. Bersell, S. Arab, B. Haring, B. Kühn, Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138, 257-270 (2009).
29. A. Jabbour, C. S. Hayward, A. M. Keogh, E. Kotlyar, J. A. McCrohon, J. F. England, R. Amor, X. Liu, X. Y. Li, M. D. Zhou, R. M. Graham, P. S. Macdonald, Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses. Eur. J. Heart Fail. 13, 83-92 (2011).
30. K. Kikuchi, J. E. Holdway, A. A. Werdich, R. M. Anderson, Y. Fang, G. F. Egnaczyk, T. Evans, C. A. Macrae, D. Y. Stainier, K. D. Poss, Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes. Nature 464, 601-605 (2010).
31. C. Jopling, E. Sleep, M. Raya, M. Martí, A. Raya, J. C. Izpisúa Belmonte, Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation. Nature 464, 606-609 (2010).
32. S. K. Sanganalmath, R. Bolli, Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ. Res. 113, 810-834 (2013).
33. P. W. Burridge, G. Keller, J. D. Gold, J. C. Wu, Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10, 16-28 (2012).
34. J. Nussbaum, E. Minami, M. A. Laflamme, J. A. Virag, C. B. Ware, A. Masino, V. Muskheli, L. Pabon, H. Reinecke, C. E. Murry, Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J. 21, 1345-1357 (2007).
35. J. Y. Min, Y. Yang, M. F. Sullivan, Q. Ke, K. L. Converso, Y. Chen, J. P. Morgan, Y. F. Xiao, Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J. Thorac. Cardiovasc. Surg. 125, 361-369 (2003).
36. M. A. Laflamme, K. Y. Chen, A. V. Naumova, V. Muskheli, J. A. Fugate, S. K. Dupras, H. Reinecke, C. Xu, M. Hassanipour, S. Police, C. O'Sullivan, L. Collins, Y. Chen, E. Minami, E. A. Gill, S. Ueno, C. Yuan, J. Gold, C. E. Murry, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024 (2007).
37. Y. Shiba, S. Fernandes, W. Z. Zhu, D. Filice, V. Muskheli, J. Kim, N. J. Palpant, J. Gantz, K. W. Moyes, H. Reinecke, B. Van Biber, T. Dardas, J. L. Mignone, A. Izawa, R. Hanna, M. Viswanathan, J. D. Gold, M. I. Kotlikoff, N. Sarvazyan, M. W. Kay, C. E. Murry, M. A. Laflamme, Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325 (2012).
38. L. R. Madden, D. J. Mortisen, E. M. Sussman, S. K. Dupras, J. A. Fugate, J. L. Cuy, K. D. Hauch, M. A. Laflamme, C. E. Murry, B. D. Ratner, Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl. Acad. Sci. U.S.A. 107, 15211-15216 (2010).
39. J. J. Chong, X. Yang, C. W. Don, E. Minami, Y. W. Liu, J. J. Weyers, W. M. Mahoney, B. Van Biber, N. J. Palpant, J. A. Gantz, J. A. Fugate, V. Muskheli, G. M. Gough, K. W. Vogel, C. A. Astley, C. E. Hotchkiss, A. Baldessari, L. Pabon, H. Reinecke, E. A. Gill, V. Nelson, H. P. Kiem, M. A. Laflamme, C. E. Murry, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 10.1038/nature13233 (2014).
40. Y. N. Tallini, K. S. Greene, M. Craven, A. Spealman, M. Breitbach, J. Smith, P. J. Fisher, M. Steffey, M. Hesse, R. M. Doran, A. Woods, B. Singh, A. Yen, B. K. Fleischmann, M. I. Kotlikoff, c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc. Natl. Acad. Sci. U.S.A. 106, 1808-1813 (2009).
41. A. P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, A. Leri, J. Kajstura, B. Nadal-Ginard, P. Anversa, Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763-776 (2003).
42. C. Bearzi, M. Rota, T. Hosoda, J. Tillmanns, A. Nascimbene, A. De Angelis, S. Yasuzawa-Amano, I. Trofimova, R. W. Siggins, N. Lecapitaine, S. Cascapera, A. P. Beltrami, D. A. D'Alessandro, E. Zias, F. Quaini, K. Urbanek, R. E. Michler, R. Bolli, J. Kajstura, A. Leri, P. Anversa, Human cardiac stem cells. Proc. Natl. Acad. Sci. U.S.A. 104, 14068-14073 (2007).
43. G. M. Ellison, C. Vicinanza, A. J. Smith, I. Aquila, A. Leone, C. D. Waring, B. J. Henning, G. G. Stirparo, R. Papait, M. Scarfò, V. Agosti, G. Viglietto, G. Condorelli, C. Indolfi, S. Ottolenghi, D. Torella, B. Nadal-Ginard, Adult c-kitpos cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154, 827-842 (2013).
44. S. Fazel, M. Cimini, L. Chen, S. Li, D. Angoulvant, P. Fedak, S. Verma, R. D. Weisel, A. Keating, R. K. Li, Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J. Clin. Invest. 116, 1865-1877 (2006).
45. M. M. Zaruba, M. Soonpaa, S. Reuter, L. J. Field, Cardiomyogenic potential of C-kit+- expressing cells derived from neonatal and adult mouse hearts. Circulation 121, 1992-2000 (2010).
46. J. Kajstura, M. Rota, D. Cappetta, B. Ogórek, C. Arranto, Y. Bai, J. Ferreira-Martins, S. Signore, F. Sanada, A. Matsuda, J. Kostyla, M. V. Caballero, C. Fiorini, D. A. D'Alessandro, R. E. Michler, F. del Monte, T. Hosoda, M. A. Perrella, A. Leri, B. A. Buchholz, J. Loscalzo, P. Anversa, Cardiomyogenesis in the aging and failing human heart. Circulation 126, 1869-1881 (2012).
47. R. Bolli, A. R. Chugh, D. D 'Amario, J. H. Loughran, M. F. Stoddard, S. Ikram, G. M. Beache, S. G. Wagner, A. Leri, T. Hosoda, F. Sanada, J. B. Elmore, P. Goichberg, D. Cappetta, N. K. Solankhi, I. Fahsah, D. G. Rokosh, M. S. Slaughter, J. Kajstura, P. Anversa, Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378, 1847-1857 (2011).
48. A. R. Chugh, G. M. Beache, J. H. Loughran, N. Mewton, J. B. Elmore, J. Kajstura, P. Pappas, A. Tatooles, M. F. Stoddard, J. A. Lima, M. S. Slaughter, P. Anversa, R. Bolli, Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126, S54-S64 (2012).
49. R. R. Smith, L. Barile, H. C. Cho, M. K. Leppo, J. M. Hare, E. Messina, A. Giacomello, M. R. Abraham, E. Marbán, Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896-908 (2007).
50. D. R. Davis, Y. Zhang, R. R. Smith, K. Cheng, J. Terrovitis, K. Malliaras, T. S. Li, A. White, R. Makkar, E. Marbán, Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLOS One 4, e7195 (2009).
51. I. Chimenti, R. R. Smith, T. S. Li, G. Gerstenblith, E. Messina, A. Giacomello, E. Marbán, Relative roles of direct regeneration versus paracrine effects of human cardiospherederived cells transplanted into infarcted mice. Circ. Res. 106, 971-980 (2010).
52. R. R. Makkar, R. R. Smith, K. Cheng, K. Malliaras, L. E. Thomson, D. Berman, L. S. Czer, L. Marbán, A. Mendizabal, P. V. Johnston, S. D. Russell, K. H. Schuleri, A. C. Lardo, G. Gerstenblith, E. Marbán, Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 379, 895-904 (2012).
53. K. Malliaras, R. R. Makkar, R. R. Smith, K. Cheng, E. Wu, R. O. Bonow, L. Marbán, A. Mendizabal, E. Cingolani, P. V. Johnston, G. Gerstenblith, K. H. Schuleri, A. C. Lardo, E. Marbán, Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J. Am. Coll. Cardiol. 63, 110-122 (2014).
54. K. A. Jackson, S. M. Majka, H. Wang, J. Pocius, C. J. Hartley, M. W. Majesky, M. L. Entman, L. H. Michael, K. K. Hirschi, M. A. Goodell, Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107, 1395-1402 (2001).
55. A. Bayes-Genis, M. Salido, F. Solé Ristol, M. Puig, V. Brossa, M. Campreciós, J. M. Corominas, M. L. Mariñoso, T. Baró, M. C. Vela, S. Serrano, J. M. Padró, A. Bayes de Luna, J. Cinca, Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts. Cardiovasc. Res. 56, 404-410 (2002).
56. M. A. Laflamme, D. Myerson, J. E. Saffitz, C. E. Murry, Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ. Res. 90, 634-640 (2002).
57. F. Quaini, K. Urbanek, A. P. Beltrami, N. Finato, C. A. Beltrami, B. Nadal-Ginard, J. Kajstura, A. Leri, P. Anversa, Chimerism of the transplanted heart. N. Engl. J. Med. 346, 5-15 (2002).
58. A. Deb, S. Wang, K. A. Skelding, D. Miller, D. Simper, N. M. Caplice, Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 107, 1247-1249 (2003).
59. D. Orlic, J. Kajstura, S. Chimenti, I. Jakoniuk, S. M. Anderson, B. Li, J. Pickel, R. McKay, B. Nadal-Ginard, D. M. Bodine, A. Leri, P. Anversa, Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
60. L. B. Balsam, A. J. Wagers, J. L. Christensen, T. Kofidis, I. L. Weissman, R. C. Robbins, Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428, 668-673 (2004).
61. J. M. Nygren, S. Jovinge, M. Breitbach, P. Säwén, W. Röll, J. Hescheler, J. Taneera, B. K. Fleischmann, S. E. Jacobsen, Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10, 494-501 (2004).
62. B. Assmus, A. Rolf, S. Erbs, A. Elsässer, W. Haberbosch, R. Hambrecht, H. Tillmanns, J. Yu, R. Corti, D. G. Mathey, C. W. Hamm, T. Süselbeck, T. Tonn, S. Dimmeler, T. Dill, A. M. Zeiher, V. Schächinger; REPAIR-AMI Investigators, Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ. Heart Fail. 3, 89-96 (2010).
63. B. Vrtovec, G. Poglajen, L. Lezaic, M. Sever, D. Domanovic, P. Cernelc, A. Socan, S. Schrepfer, G. Torre-Amione, F. Haddad, J. C. Wu, Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-Year follow-up. Circ. Res. 112, 165-173 (2013).
64. M. Yousef, C. M. Schannwell, M. Köstering, T. Zeus, M. Brehm, B. E. Strauer, The BALANCE Study: Clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 53, 2262-2269 (2009).
65. S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, W. Desmet, M. Kalantzi, L. Herbots, P. Sinnaeve, J. Dens, J. Maertens, F. Rademakers, S. Dymarkowski, O. Gheysens, J. Van Cleemput, G. Bormans, J. Nuyts, A. Belmans, L. Mortelmans, M. Boogaerts, F. Van de Werf, Autologous bone marrow-derived stem-cell transfer in patients with STsegment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367, 113-121 (2006).
66. A. Hirsch, R. Nijveldt, P. A. van der Vleuten, J. G. Tijssen, W. J. van der Giessen, R. A. Tio, J. Waltenberger, J. M. ten Berg, P. A. Doevendans, W. R. Aengevaeren, J. J. Zwaginga, B. J. Biemond, A. C. van Rossum, J. J. Piek, F. Zijlstra; HEBE Investigators, Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: Results of the randomized controlled HEBE trial. Eur. Heart J. 32, 1736-1747 (2011).
67. J. H. Traverse, T. D. Henry, S. G. Ellis, C. J. Pepine, J. T. Willerson, D. X. Zhao, J. R. Forder, B. J. Byrne, A. K. Hatzopoulos, M. S. Penn, E. C. Perin, K. W. Baran, J. Chambers, C. Lambert, G. Raveendran, D. I. Simon, D. E. Vaughan, L. M. Simpson, A. P. Gee, D. A. Taylor, C. R. Cogle, J. D. Thomas, G. V. Silva, B. C. Jorgenson, R. E. Olson, S. Bowman, J. Francescon, C. Geither, E. Handberg, D. X. Smith, S. Baraniuk, L. B. Piller, C. Loghin, D. Aguilar, S. Richman, C. Zierold, J. Bettencourt, S. L. Sayre, R. W. Vojvodic, S. I. Skarlatos, D. J. Gordon, R. F. Ebert, M. Kwak, L. A. Moye, R. D. Simari; Cardiovascular Cell Therapy ResearchNetwork, Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: The LateTIME randomized trial. JAMA 306, 2110-2119 (2011).
68. D. Sürder, R.Manka, V. Lo Cicero, T. Moccetti, K. Rufibach, S. Soncin, L. Turchetto, M. Radrizzani, G. Astori, J. Schwitter, P. Erne, M. Zuber, C. Auf derMaur, P. Jamshidi, O. Gaemperli, S.Windecker, A. Moschovitis, A. Wahl, I. Bühler, C. Wyss, S. Kozerke, U. Landmesser, T. F. Lüscher, R. Corti, Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: Effects on global left ventricular function. Circulation 127, 1968-1979 (2013).
69. K. U. Hong, Q. H. Li, Y. Guo, N. S. Patton, A. Moktar, A. Bhatnagar, R. Bolli, A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice. Basic Res. Cardiol. 108, 346 (2013).
70. V. Schächinger, A. Aicher, N. Döbert, R. Röver, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, S. Dimmeler, A. M. Zeiher, Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium. Circulation 118, 1425-1432 (2008).
71. M. Hofmann, K. C. Wollert, G. P. Meyer, A. Menke, L. Arseniev, B. Hertenstein, A. Ganser, W. H. Knapp, H. Drexler, Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111, 2198-2202 (2005).
72. M. Gnecchi, Z. Zhang, A. Ni, V. J. Dzau, Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204-1219 (2008).
73. N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, T. Tokudome, H. Mori, K. Miyatake, S. Kitamura, Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128-1135 (2005).
74. P. Fidelis-de-Oliveira, J. P. Werneck-de-Castro, V. Pinho-Ribeiro, B. C. Shalom, J. H. Nascimento-Silva, R. H. Costa e Souza, I. S. Cruz, R. R. Rangel, R. C. Goldenberg, A. C. Campos-de-Carvalho, Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts. Cell Transplant. 21, 1011-1021 (2012).
75. M. Gnecchi, H. He, O. D. Liang, L. G. Melo, F. Morello, H. Mu, N. Noiseux, L. Zhang, R. E. Pratt, J. S. Ingwall, V. J. Dzau, Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368 (2005).
76. K. E. Hatzistergos, H. Quevedo, B. N. Oskouei, Q. Hu, G. S. Feigenbaum, I. S. Margitich, R. Mazhari, A. J. Boyle, J. P. Zambrano, J. E. Rodriguez, R. Dulce, P. M. Pattany, D. Valdes, C. Revilla, A. W. Heldman, I. McNiece, J. M. Hare, Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 107, 913-922 (2010).
77. M. Gnecchi, H. He, N. Noiseux, O. D. Liang, L. Zhang, F. Morello, H. Mu, L. G. Melo, R. E. Pratt, J. S. Ingwall, V. J. Dzau, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 20, 661-669 (2006).
78. T. Kinnaird, E. Stabile, M. S. Burnett, C. W. Lee, S. Barr, S. Fuchs, S. E. Epstein, Marrowderived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94, 678-685 (2004).
79. B. Zhou, L. B. Honor, H. He, Q. Ma, J. H. Oh, C. Butterfield, R. Z. Lin, J. M. Melero-Martin, E. Dolmatova, H. S. Duffy, A. Gise, P. Zhou, Y. W. Hu, G. Wang, B. Zhang, L. Wang, J. L. Hall, M. A. Moses, F. X. McGowan, W. T. Pu, Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121, 1894-1904 (2011).
80. F. S. Loffredo, M. L. Steinhauser, J. Gannon, R. T. Lee, Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8, 389-398 (2011).
81. S. Ohnishi, H. Sumiyoshi, S. Kitamura, N. Nagaya, Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions. FEBS Lett. 581, 3961-3966 (2007).
82. C. Huang, H. Gu, Q. Yu, M. C. Manukyan, J. A. Poynter, M. Wang, Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/ reperfusion. PLOS One 6, e29246 (2011).
83. L. Timmers, S. K. Lim, I. E. Hoefer, F. Arslan, R. C. Lai, A. A. van Oorschot, M. J. Goumans, C. Strijder, S. K. Sze, A. Choo, J. J. Piek, P. A. Doevendans, G. Pasterkamp, D. P. de Kleijn, Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6, 206-214 (2011).
84. P. C. Hsieh, V. F. Segers, M. E. Davis, C. MacGillivray, J. Gannon, J. D. Molkentin, J. Robbins, R. T. Lee, Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat. Med. 13, 970-974 (2007).
85. K. Urbanek, M. Rota, S. Cascapera, C. Bearzi, A. Nascimbene, A. De Angelis, T. Hosoda, S. Chimenti, M. Baker, F. Limana, D. Nurzynska, D. Torella, F. Rotatori, R. Rastaldo, E. Musso, F. Quaini, A. Leri, J. Kajstura, P. Anversa, Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ. Res. 97, 663-673 (2005).
86. A. von Gise, W. T. Pu, Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ. Res. 110, 1628-1645 (2012).
87. B. Zhou, Q. Ma, S. Rajagopal, S. M. Wu, I. Domian, J. Rivera-Feliciano, D. Jiang, A. von Gise, S. Ikeda, K. R. Chien, W. T. Pu, Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109-113 (2008).
88. C. L. Cai, J. C. Martin, Y. Sun, L. Cui, L. Wang, K. Ouyang, L. Yang, L. Bu, X. Liang, X. Zhang, W. B. Stallcup, C. P. Denton, A. McCulloch, J. Chen, S. M. Evans, A myocardial lineage derives from Tbx18 epicardial cells. Nature 454, 104-108 (2008).
89. N. Smart, S. Bollini, K. N. Dubé, J. M. Vieira, B. Zhou, S. Davidson, D. Yellon, J. Riegler, A. N. Price, M. F. Lythgoe, W. T. Pu, P. R. Riley, De novo cardiomyocytes from within the activated adult heart after injury. Nature 474, 640-644 (2011).
90. B. Zhou, L. B. Honor, Q. Ma, J. H. Oh, R. Z. Lin, J. M. Melero-Martin, A. von Gise, P. Zhou, T. Hu, L. He, K. H. Wu, H. Zhang, Y. Zhang, W. T. Pu, Thymosin beta 4 treatment after myocardial infarction does not reprogram epicardial cells into cardiomyocytes. J. Mol. Cell. Cardiol. 52, 43-47 (2012).
91. L. Zangi, K. O. Lui, A. von Gise, Q. Ma, W. Ebina, L. M. Ptaszek, D. Später, H. Xu, M. Tabebordbar, R. Gorbatov, B. Sena, M. Nahrendorf, D. M. Briscoe, R. A. Li, A. J. Wagers, D. J. Rossi, W. T. Pu, K. R. Chien, Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898-907 (2013).
92. A. Boni, K. Urbanek, A. Nascimbene, T. Hosoda, H. Zheng, F. Delucchi, K. Amano, A. Gonzalez, S. Vitale, C. Ojaimi, R. Rizzi, R. Bolli, K. E. Yutzey, M. Rota, J. Kajstura, P. Anversa, A. Leri, Notch1 regulates the fate of cardiac progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 105, 15529-15534 (2008).
93. M. Nemir, M. Metrich, I. Plaisance, M. Lepore, S. Cruchet, C. Berthonneche, A. Sarre, F. Radtke, T. Pedrazzini, The Notch pathways controls fibrotic and regenerative repair in the adult heart. Eur. Heart J. 10.1093/eurheartj/ehs269 (2012).
94. K. Takahashi, S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
95. M. Ieda, J. D. Fu, P. Delgado-Olguin, V. Vedantham, Y. Hayashi, B. G. Bruneau, D. Srivastava, Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
96. L. Qian, Y. Huang, C. I. Spencer, A. Foley, V. Vedantham, L. Liu, S. J. Conway, J. D. Fu, D. Srivastava, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598 (2012).
97. K. Song, Y. J. Nam, X. Luo, X. Qi, W. Tan, G. N. Huang, A. Acharya, C. L. Smith, M. D. Tallquist, E. G. Neilson, J. A. Hill, R. Bassel-Duby, E. N. Olson, Heart repair by reprogramming nonmyocytes with cardiac transcription factors. Nature 485, 599-604 (2012).
98. T. M. Jayawardena, B. Egemnazarov, E. A. Finch, L. Zhang, J. A. Payne, K. Pandya, Z. Zhang, P. Rosenberg, M. Mirotsou, V. J. Dzau, MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465-1473 (2012).
99. R. C. Addis, J. L. Ifkovits, F. Pinto, L. D. Kellam, P. Esteso, S. Rentschler, N. Christoforou, J. A. Epstein, J. D. Gearhart, Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success. J. Mol. Cell. Cardiol. 60, 97-106 (2013).
100. R. Wada, N. Muraoka, K. Inagawa, H. Yamakawa, K. Miyamoto, T. Sadahiro, T. Umei, R. Kaneda, T. Suzuki, K. Kamiya, S. Tohyama, S. Yuasa, K. Kokaji, R. Aeba, R. Yozu, H. Yamagishi, T. Kitamura, K. Fukuda, M. Ieda, Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc. Natl. Acad. Sci. U.S.A. 110, 12667-12672 (2013).
101. J. D. Fu, N. R. Stone, L. Liu, C. I. Spencer, L. Qian, Y. Hayashi, P. Delgado-Olguin, S. Ding, B. G. Bruneau, D. Srivastava, Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports 1, 235-247 (2013).
102. Y. J. Nam, K. Song, X. Luo, E. Daniel, K. Lambeth, K. West, J. A. Hill, J. M. DiMaio, L. A. Baker, R. Bassel-Duby, E. N. Olson, Reprogramming of human fibroblasts toward a cardiac fate. Proc. Natl. Acad. Sci. U.S.A. 110, 5588-5593 (2013).
103. J. F. Islas, Y. Liu, K. C. Weng, M. J. Robertson, S. Zhang, A. Prejusa, J. Harger, D. Tikhomirova, M. Chopra, D. Iyer, M. Mercola, R. G. Oshima, J. T. Willerson, V. N. Potaman, R. J. Schwartz, Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors. Proc. Natl. Acad. Sci. U.S.A. 109, 13016-13021 (2012).
104. P. Menasché, O. Alfieri, S. Janssens, W. McKenna, H. Reichenspurner, L. Trinquart, J. T. Vilquin, J. P. Marolleau, B. Seymour, J. Larghero, S. Lake, G. Chatellier, S. Solomon, M. Desnos, A. A. Hagège, The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189-1200 (2008).
105. B. Assmus, J. Honold, V. Schächinger, M. B. Britten, U. Fischer-Rasokat, R. Lehmann, C. Teupe, K. Pistorius, H. Martin, N. D. Abolmaali, T. Tonn, S. Dimmeler, A. M. Zeiher, Transcoronary transplantation of progenitor cells after myocardial infarction. N. Engl. J. Med. 355, 1222-1232 (2006).